Technical Analysis for XYN - Xynomic Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
grade F 2.95 -7.81% -0.25
XYN closed down 7.81 percent on Tuesday, July 16, 2019, on 58 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical XYN trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.81%
Narrow Range Bar Range Contraction -7.81%
NR7 Range Contraction -7.81%
NR7-2 Range Contraction -7.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.81%
Narrow Range Bar Range Contraction -7.81%

Older signals for XYN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Xynomic is a clinical stage oncology-focused biopharmaceutical company. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma (in combination with pazopanib) and non-Hodgkin's lymphoma (as a single agent). Xynomic Pharma's other clinical stage drug candidate XP-105 (BI 860585) is a Phase 2 ready, ATP-competitive mTORC1/2 inhibitor against solid tumors. Xynomic's pre-clinical oncology drug candidate XP-102 (BI 882370) is a pan-RAF inhibitor.
Manufacturing Chemical Compounds Organic Compounds Solid Tumors Lymphoma Antineoplastic Drugs Renal Cell Carcinoma Oncology Focused Biopharmaceutical Xp
Is XYN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.0
52 Week Low 2.29
Average Volume 48,641
200-Day Moving Average 8.7518
50-Day Moving Average 4.425
20-Day Moving Average 3.3123
10-Day Moving Average 3.1855
Average True Range 0.3891
ADX 16.34
+DI 17.6411
-DI 29.8155
Chandelier Exit (Long, 3 ATRs ) 2.852
Chandelier Exit (Short, 3 ATRs ) 3.7773
Upper Bollinger Band 3.6772
Lower Bollinger Band 2.9474
Percent B (%b) 0.0
BandWidth 22.033028
MACD Line -0.3213
MACD Signal Line -0.3999
MACD Histogram 0.0786
Fundamentals Value
Market Cap 23.54 Million
Num Shares 7.98 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.70
Resistance 3 (R3) 3.67 3.39 3.58
Resistance 2 (R2) 3.39 3.20 3.41 3.53
Resistance 1 (R1) 3.17 3.08 3.03 3.20 3.49
Pivot Point 2.89 2.89 2.82 2.91 2.89
Support 1 (S1) 2.67 2.70 2.53 2.70 2.41
Support 2 (S2) 2.39 2.58 2.41 2.37
Support 3 (S3) 2.17 2.39 2.33
Support 4 (S4) 2.20